BioMed Central has commenced publication of the following open access journal:
Title: Experimental & Translational Stroke Medicine
Editor(s)-in-chief: Wolf-RÃ¼diger SchÃ¤bitz
Abbreviation: Exp Transl Stroke Med
This journal is an open access, peer-reviewed, online journal dedicated to presenting original research and review articles on any topic that relates to identifying and solving problems in translational stroke research. By offering a high-visibility forum for new insights and discussions, the journal aims to help improve the quality of experimental stroke research in order to increase the rate of successful translation of novel treatment strategies into clinical practice.
Basic stroke research creates and explores in vitro and in vivo models with the objective of gaining novel insights into the pathophysiological processes occurring during ischemic brain damage with subsequent application to innovative treatment strategies.
ETSM invites content related to: experimental stroke models and their methodological limitations; preclinical treatment trials; improved diagnostic methods that could be translated to human stroke; the pathophysiology of stroke (with special emphasis on the ischemic penumbra, thrombus formation, neuro-protection, pre-/post conditioning, regeneration and repair) and work on the benefits and limitations of experimental disease models in the field of neurology, when applicable to stroke.
Manuscripts submitted to the journal will be evaluated initially by the Editor-in-Chief or Handling Editors, and appropriate manuscripts then sent for peer review to recognized experts in the field, who may be members of the Editorial Board or external peer reviewers. The current articles are in their provisional PDF format, but the full-text and final PDF versions will be available shortly.